Clinicopathological Features and Prognosis of Small Cell Carcinoma of the Cervix
10.1007/sl1596-010-0554-x
- Author:
LIU JIE
1
;
LI YUAN
;
LI SHUANG
;
WANG DAN
;
HU TING
;
MENG YUHAN
;
MA DING
;
CAI HONGBING
;
WANG ZEHUA
;
XIONG CHENGLIANG
;
ZHANG HUIPING
Author Information
1. Reproductive Medicine Center, Research Institute for Family Planning of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
- Keywords:
cervix;
small cell carcinoma;
clinicopathological features;
prognosis
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2010;30(5):626-630
- CountryChina
- Language:Chinese
-
Abstract:
Small cell carcinoma of cervix (SCCC) is a rare disease with highly aggressive behaviour and is pathologically hard to diagnose. In this study, the clinicopathological features, diagnosis,treatment and prognosis of the condition were examined. Clinical records and follow-up data of 7 cases of SCCC were retrospectively studied. Our results showed that five non-recurrent cases initially presented irregular vaginal bleeding or increased apocenosis of varying degrees. Pathological examination revealed that the stroma was diffusely infiltrated with small monomorphous cells ranging from round to oval shape. Three cases were immunohistochemically confirmed. One case was accompanied with squamous cell cancer. Of the 7 cases, one case was classified as stage Ⅰ bl, two stage Ⅰ b2,one stage Ⅱ a, one stage Ⅱ b, and one stage Ⅲb. On the basis of their stages of condition, one subject with stage Ⅲ b underwent chemotherapy, and one with stage Ib2 received extensive hysterectomy plus pelvic lymphadenectomy, while the other 5 cases were treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy. Of the 7 patients, 4 had relapse-free survival of 14, 14, 16 and 28 months respectively.It is concluded that SCCC is an aggressive tumor with propensity for early pelvis lymph node metastases. Early-stage patients should be treated by extensive hysterectomy and pelvic lymphadenectomy in combination with pre- and/or post-operative adjuvant chemotherapy and radiotherapy.
